気管支拡張症と治療可能な特徴:概念から臨床実践への道のり
Pau Marrades1, Alessandro De Angelis2, Alessandra Iorfida3
1Respiratory Department, Hospital Clínic, University of Barcelona, IDIBAPS, CIBERES, Barcelona, Spain.
Respiratory medicine
|December 20, 2025
まとめ
治療可能な特徴(TT)アプローチは、気管支拡張症に対する精密医療戦略を提供し、転帰を改善するために特定の患者特性を特定し、標的とする。このフレームワークは、患者中心の結果を改善するための治療の個別化を目指している。
科学分野:
- 肺医学; 精密医療; 呼吸器疾患
背景:
- 気管支拡張症は、治療選択肢が限られている慢性気道疾患です。治療可能な特徴(TT)アプローチは、複雑な状態に対する個別化医療に焦点を当てています。TTは、測定可能で修正可能な患者の特性を特定します。
研究 の 目的:
- 気管支拡張症に対する治療可能な特徴(TT)フレームワークを更新すること。現在の文献をレビューし、他の肺疾患と比較すること。TTフレームワーク内での診断ツール、モニタリング、および新しい治療法を探求すること。
主な方法:
- PubMedでの網羅的な文献検索(2025年7月1日まで)。臨床研究およびトランスレーショナル研究の組み込み。他の肺疾患との気管支拡張症におけるTTの比較。
主要な成果:
- 気管支拡張症患者は、喀痰、感染、増悪、炎症、併存疾患など、複数の特徴を呈することがよくあります。現在の治療法は一部の特徴に対処していますが、エビデンスは限られています。好中球経路を標的とする新しい治療法は、特定の内型に有望です。
結論:
- TTアプローチは、気管支拡張症における精密医療への移行を意味します。この戦略は、患者の転帰と予後を向上させる可能性があります。今後の研究では、患者の好みを考慮した臨床研究を通じてTTアプローチを検証する必要があります。
さらに関連する動画
関連する概念動画
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Cystic Fibrosis: Management
443
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
443
Cystic Fibrosis: Pathogenesis
679
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
679
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
COPD: Management Using Bronchodilators and Corticosteroids
700
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
700


